DP13 - A Phase II Study in Patients With Primary Aldosteronism
Clinical trial NCT04007406 · COMPLETED
Trial details
- NCT number
- NCT04007406
- Sponsor
- Damian Pharma AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-21
- Primary completion
- 2022-05-02
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.